| 5HU9: reference: Discovery and characterization of a novel potent type II native and mutant BCR-ABL inhibitor (CHMFL-074) for Chronic Myeloid Leukemia (CML)., Liu F, Wang B, Wang Q, Qi Z, Chen C, Kong LL, Chen JY, Liu X, Wang A, Hu C, Wang W, Wang H, Wu F, Ruan Y, Qi S, Liu J, Zou F, Hu Z, Wang W, Wang L, Zhang S, Yun CH, Zhai Z, Liu J, Liu Q, Oncotarget. 2016 Jun 14. doi: 10.18632/oncotarget.10037. PMID: 27322145 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).